Risk stratification using serum concentrations of cardiac troponin T in patients with end-stage renal disease on chronic maintenance dialysis
- 25 September 2001
- journal article
- research article
- Published by Elsevier in Clinica Chimica Acta; International Journal of Clinical Chemistry
- Vol. 312 (1-2) , 69-79
- https://doi.org/10.1016/s0009-8981(01)00592-7
Abstract
No abstract availableKeywords
This publication has 48 references indexed in Scilit:
- Prognostic value of serum cardiac troponin I and T in chronic dialysis patients: A 1-year outcomes analysisAmerican Journal of Kidney Diseases, 1997
- Congestive heart failure in dialysis patients: Prevalence, incidence, prognosis and risk factorsKidney International, 1995
- Clinical and echocardiographic disease in patients starting end-stage renal disease therapyKidney International, 1995
- Current status of renal replacement therapy in JapanAmerican Journal of Kidney Diseases, 1995
- Changes in Brain Natriuretic Peptide and Atrial Natriuretic Peptide Plasma Concentrations During Hemodialysis in Patients with Chronic Renal FailureHormone and Metabolic Research, 1994
- Beneficial effects of metoprolol in idiopathic dilated cardiomyopathyThe Lancet, 1993
- Developmental expression of troponin I isoforms in fetal human heartFEBS Letters, 1991
- No specific organ removes atrial natriuretic peptide from the human plasma.Japanese Circulation Journal, 1989
- Congestive heart failure in dialysis patientsArchives of internal medicine (1960), 1988
- Effects of Enalapril on Mortality in Severe Congestive Heart FailureNew England Journal of Medicine, 1987